

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 9.80208830 |
| 2 | central nervous system myelination (GO:0022010) | 9.80208830 |
| 3 | * myelination (GO:0042552) | 6.46684356 |
| 4 | * ensheathment of neurons (GO:0007272) | 6.44221531 |
| 5 | * axon ensheathment (GO:0008366) | 6.44221531 |
| 6 | oligodendrocyte differentiation (GO:0048709) | 5.80845253 |
| 7 | fatty acid elongation (GO:0030497) | 5.59959604 |
| 8 | photoreceptor cell differentiation (GO:0046530) | 5.15039154 |
| 9 | eye photoreceptor cell differentiation (GO:0001754) | 5.15039154 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 5.14927900 |
| 11 | exploration behavior (GO:0035640) | 5.11451955 |
| 12 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.08515714 |
| 13 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 5.01262888 |
| 14 | creatine metabolic process (GO:0006600) | 5.00917405 |
| 15 | cellular potassium ion homeostasis (GO:0030007) | 4.89780978 |
| 16 | potassium ion import (GO:0010107) | 4.81131443 |
| 17 | presynaptic membrane assembly (GO:0097105) | 4.67154725 |
| 18 | astrocyte development (GO:0014002) | 4.64597926 |
| 19 | negative regulation of neurotransmitter transport (GO:0051589) | 4.63773971 |
| 20 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.50351655 |
| 21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.50174198 |
| 22 | potassium ion homeostasis (GO:0055075) | 4.49505341 |
| 23 | sodium ion export (GO:0071436) | 4.46500709 |
| 24 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.46036963 |
| 25 | presynaptic membrane organization (GO:0097090) | 4.43479903 |
| 26 | positive regulation of osteoblast proliferation (GO:0033690) | 4.34250665 |
| 27 | asymmetric protein localization (GO:0008105) | 4.30771054 |
| 28 | apical protein localization (GO:0045176) | 4.27630386 |
| 29 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.19615121 |
| 30 | L-amino acid import (GO:0043092) | 4.19579011 |
| 31 | amino acid import (GO:0043090) | 4.17579524 |
| 32 | peripheral nervous system axon ensheathment (GO:0032292) | 4.06951820 |
| 33 | myelination in peripheral nervous system (GO:0022011) | 4.06951820 |
| 34 | cholesterol biosynthetic process (GO:0006695) | 4.05687384 |
| 35 | substantia nigra development (GO:0021762) | 4.04988474 |
| 36 | neurotransmitter uptake (GO:0001504) | 4.01860599 |
| 37 | mechanosensory behavior (GO:0007638) | 3.90620360 |
| 38 | negative regulation of protein localization to cell surface (GO:2000009) | 3.89059937 |
| 39 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.88612995 |
| 40 | regulation of respiratory system process (GO:0044065) | 3.86308784 |
| 41 | vocalization behavior (GO:0071625) | 3.81027551 |
| 42 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.80599979 |
| 43 | negative regulation of axon extension (GO:0030517) | 3.68707408 |
| 44 | synaptic vesicle maturation (GO:0016188) | 3.66267662 |
| 45 | neuron projection regeneration (GO:0031102) | 3.64244735 |
| 46 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.63370396 |
| 47 | locomotory exploration behavior (GO:0035641) | 3.60188380 |
| 48 | glial cell differentiation (GO:0010001) | 3.59845061 |
| 49 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.59149870 |
| 50 | regulation of synapse structural plasticity (GO:0051823) | 3.58865497 |
| 51 | negative regulation of axonogenesis (GO:0050771) | 3.58129417 |
| 52 | auditory behavior (GO:0031223) | 3.57962605 |
| 53 | Leydig cell differentiation (GO:0033327) | 3.57477758 |
| 54 | myelin maintenance (GO:0043217) | 3.56931627 |
| 55 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.56494103 |
| 56 | synaptic transmission, glutamatergic (GO:0035249) | 3.53171673 |
| 57 | enteric nervous system development (GO:0048484) | 3.52614933 |
| 58 | acidic amino acid transport (GO:0015800) | 3.50513637 |
| 59 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.48215522 |
| 60 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.47455868 |
| 61 | sterol biosynthetic process (GO:0016126) | 3.47133612 |
| 62 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.45014548 |
| 63 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.45002267 |
| 64 | transmission of nerve impulse (GO:0019226) | 3.44994532 |
| 65 | regulation of collateral sprouting (GO:0048670) | 3.44151807 |
| 66 | cAMP-mediated signaling (GO:0019933) | 3.43022312 |
| 67 | regulation of axon regeneration (GO:0048679) | 3.41521945 |
| 68 | regulation of neuron projection regeneration (GO:0070570) | 3.41521945 |
| 69 | glycerophospholipid catabolic process (GO:0046475) | 3.41302146 |
| 70 | growth hormone secretion (GO:0030252) | 3.41025942 |
| 71 | protein localization to synapse (GO:0035418) | 3.34233042 |
| 72 | response to lipoprotein particle (GO:0055094) | 3.33796364 |
| 73 | synaptic vesicle exocytosis (GO:0016079) | 3.31238957 |
| 74 | glutamate secretion (GO:0014047) | 3.31134656 |
| 75 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.30416046 |
| 76 | lens fiber cell development (GO:0070307) | 3.30166649 |
| 77 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.30046903 |
| 78 | dermatan sulfate biosynthetic process (GO:0030208) | 3.30018011 |
| 79 | establishment of mitochondrion localization (GO:0051654) | 3.27280048 |
| 80 | regulation of neurotransmitter uptake (GO:0051580) | 3.25555899 |
| 81 | limb bud formation (GO:0060174) | 3.24499556 |
| 82 | positive regulation of growth hormone secretion (GO:0060124) | 3.24406297 |
| 83 | cyclic-nucleotide-mediated signaling (GO:0019935) | 3.21182867 |
| 84 | dendrite morphogenesis (GO:0048813) | 3.20321658 |
| 85 | cerebellar Purkinje cell layer development (GO:0021680) | 3.19311157 |
| 86 | virion attachment to host cell (GO:0019062) | 3.18961658 |
| 87 | adhesion of symbiont to host cell (GO:0044650) | 3.18961658 |
| 88 | chondroitin sulfate biosynthetic process (GO:0030206) | 3.18747294 |
| 89 | Sertoli cell development (GO:0060009) | 3.18672516 |
| 90 | * positive regulation of gliogenesis (GO:0014015) | 3.15939775 |
| 91 | astrocyte differentiation (GO:0048708) | 3.15786683 |
| 92 | cerebellar granule cell differentiation (GO:0021707) | 3.14872881 |
| 93 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.14231818 |
| 94 | neuromuscular process controlling balance (GO:0050885) | 3.12264319 |
| 95 | positive regulation of neurological system process (GO:0031646) | 3.11269654 |
| 96 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.10824160 |
| 97 | negative regulation of myoblast differentiation (GO:0045662) | 3.09889820 |
| 98 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.09361622 |
| 99 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.09203784 |
| 100 | response to auditory stimulus (GO:0010996) | 3.08918281 |
| 101 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.08673385 |
| 102 | glutamate receptor signaling pathway (GO:0007215) | 3.07593806 |
| 103 | cellular sodium ion homeostasis (GO:0006883) | 3.07564629 |
| 104 | membrane hyperpolarization (GO:0060081) | 3.06981711 |
| 105 | regulation of growth hormone secretion (GO:0060123) | 3.06895303 |
| 106 | regulation of synaptic vesicle transport (GO:1902803) | 3.06637662 |
| 107 | L-glutamate transport (GO:0015813) | 3.06465951 |
| 108 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.03303090 |
| 109 | long-term synaptic potentiation (GO:0060291) | 3.03008565 |
| 110 | peripheral nervous system development (GO:0007422) | 3.01633602 |
| 111 | isoprenoid biosynthetic process (GO:0008299) | 3.01538925 |
| 112 | positive regulation of p38MAPK cascade (GO:1900745) | 3.01415633 |
| 113 | protein palmitoylation (GO:0018345) | 3.00554827 |
| 114 | regulation of respiratory gaseous exchange (GO:0043576) | 2.99088826 |
| 115 | response to methylmercury (GO:0051597) | 2.98819649 |
| 116 | glial cell development (GO:0021782) | 2.98616170 |
| 117 | regulation of circadian sleep/wake cycle (GO:0042749) | 2.97309861 |
| 118 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 2.97309861 |
| 119 | activated T cell proliferation (GO:0050798) | 2.97086701 |
| 120 | dermatan sulfate metabolic process (GO:0030205) | 2.92022454 |
| 121 | regulation of somitogenesis (GO:0014807) | 2.91451567 |
| 122 | * regulation of gliogenesis (GO:0014013) | 2.91042109 |
| 123 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.90810986 |
| 124 | adult walking behavior (GO:0007628) | 2.90575795 |
| 125 | neuron recognition (GO:0008038) | 2.90239311 |
| 126 | positive regulation of actin filament depolymerization (GO:0030836) | 2.89624834 |
| 127 | neurotransmitter secretion (GO:0007269) | 2.89420940 |
| 128 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.88524893 |
| 129 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.87244419 |
| 130 | neuronal ion channel clustering (GO:0045161) | 2.86782813 |
| 131 | neuroblast proliferation (GO:0007405) | 2.85104819 |
| 132 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.84757406 |
| 133 | lateral sprouting from an epithelium (GO:0060601) | 2.81639870 |
| 134 | innervation (GO:0060384) | 2.81104193 |
| 135 | nephron tubule formation (GO:0072079) | 2.80058825 |
| 136 | neural nucleus development (GO:0048857) | 2.79899494 |
| 137 | dendritic spine morphogenesis (GO:0060997) | 2.79841633 |
| 138 | negative regulation of smoothened signaling pathway (GO:0045879) | 2.79163195 |
| 139 | * positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.77845927 |
| 140 | chondroitin sulfate catabolic process (GO:0030207) | 2.77761909 |
| 141 | import into cell (GO:0098657) | 2.77028777 |
| 142 | nerve growth factor signaling pathway (GO:0038180) | 2.74186985 |
| 143 | positive regulation of astrocyte differentiation (GO:0048711) | 2.73084613 |
| 144 | * positive regulation of glial cell differentiation (GO:0045687) | 2.70180650 |
| 145 | mammary gland alveolus development (GO:0060749) | 2.69916958 |
| 146 | response to redox state (GO:0051775) | 2.69368598 |
| 147 | cellular response to epinephrine stimulus (GO:0071872) | 2.66534652 |
| 148 | very long-chain fatty acid metabolic process (GO:0000038) | 2.66471447 |
| 149 | neurotransmitter catabolic process (GO:0042135) | 2.66169807 |
| 150 | * regulation of oligodendrocyte differentiation (GO:0048713) | 2.66047947 |
| 151 | axon development (GO:0061564) | 2.65525325 |
| 152 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.64584396 |
| 153 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.64584396 |
| 154 | axonal fasciculation (GO:0007413) | 2.63276572 |
| 155 | postsynaptic membrane organization (GO:0001941) | 2.62114077 |
| 156 | positive regulation of synapse assembly (GO:0051965) | 2.60360980 |
| 157 | L-serine transport (GO:0015825) | 2.56231005 |
| 158 | layer formation in cerebral cortex (GO:0021819) | 2.53555501 |
| 159 | Rap protein signal transduction (GO:0032486) | 2.51611199 |
| 160 | peptidyl-cysteine modification (GO:0018198) | 2.50750596 |
| 161 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.47321380 |
| 162 | membrane assembly (GO:0071709) | 2.47236499 |
| 163 | * regulation of glial cell differentiation (GO:0045685) | 2.46130656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.99120855 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.53212314 |
| 3 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.89685872 |
| 4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.88163497 |
| 5 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.74855184 |
| 6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.74374700 |
| 7 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.63778053 |
| 8 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.60121153 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.57188978 |
| 10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.57188978 |
| 11 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.40828179 |
| 12 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.39697393 |
| 13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37417551 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.28705870 |
| 15 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.25368695 |
| 16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.25011348 |
| 17 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.23851852 |
| 18 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.20442423 |
| 19 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.19352682 |
| 20 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.13830748 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13718258 |
| 22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11703019 |
| 23 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.07746576 |
| 24 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.06746038 |
| 25 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.98488200 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.96451442 |
| 27 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.94255938 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88482611 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.86885123 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.81220595 |
| 31 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.75517021 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.73675936 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.72099497 |
| 34 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.69974562 |
| 35 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.69277561 |
| 36 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.68815399 |
| 37 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.67027072 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.66240978 |
| 39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.64738634 |
| 40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.61567753 |
| 41 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.60811686 |
| 42 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.59751023 |
| 43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.59623082 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56954490 |
| 45 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.55049847 |
| 46 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.50485289 |
| 47 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.48081866 |
| 48 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.47034716 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46460803 |
| 50 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46235636 |
| 51 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.44009541 |
| 52 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.42987988 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41614963 |
| 54 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40624064 |
| 55 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.39621275 |
| 56 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.37748231 |
| 57 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.35650203 |
| 58 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.35022666 |
| 59 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33744820 |
| 60 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31094141 |
| 61 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.29057874 |
| 62 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.28893223 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25211839 |
| 64 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.24198772 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21446597 |
| 66 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.17975407 |
| 67 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.17682038 |
| 68 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.16610789 |
| 69 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.12551609 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11777995 |
| 71 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11542068 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10817983 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10433242 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10391302 |
| 75 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.10286598 |
| 76 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10269483 |
| 77 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08991758 |
| 78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07414936 |
| 79 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.07296601 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06040448 |
| 81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.05921474 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05213427 |
| 83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05115932 |
| 84 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04792379 |
| 85 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04080894 |
| 86 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.02289990 |
| 87 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01994736 |
| 88 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 1.01905994 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01596150 |
| 90 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.01531627 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01331085 |
| 92 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01282949 |
| 93 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01104716 |
| 94 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00797373 |
| 95 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00306619 |
| 96 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.00279082 |
| 97 | AR_19668381_ChIP-Seq_PC3_Human | 1.00230544 |
| 98 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99272373 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98667790 |
| 100 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98117601 |
| 101 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.97265627 |
| 102 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97070825 |
| 103 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96460250 |
| 104 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95688150 |
| 105 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94164375 |
| 106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93998389 |
| 107 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93998389 |
| 108 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 0.93961837 |
| 109 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.90601376 |
| 110 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90327408 |
| 111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89957795 |
| 112 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89730035 |
| 113 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89181947 |
| 114 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89046830 |
| 115 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.88554353 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88515014 |
| 117 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.87980624 |
| 118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87836732 |
| 119 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.87288698 |
| 120 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86586730 |
| 121 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.86511849 |
| 122 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86282999 |
| 123 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86113349 |
| 124 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.85254723 |
| 125 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.83646762 |
| 126 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.83401191 |
| 127 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83160399 |
| 128 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.82485751 |
| 129 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.82326340 |
| 130 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.81910872 |
| 131 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.80565844 |
| 132 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79939120 |
| 133 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.79434849 |
| 134 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.79421668 |
| 135 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.79210942 |
| 136 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79131552 |
| 137 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77274253 |
| 138 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.76956129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.60390758 |
| 2 | MP0003880_abnormal_central_pattern | 4.01730446 |
| 3 | MP0003136_yellow_coat_color | 3.32333367 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.16656319 |
| 5 | MP0005167_abnormal_blood-brain_barrier | 2.87397265 |
| 6 | MP0003690_abnormal_glial_cell | 2.86825091 |
| 7 | * MP0000778_abnormal_nervous_system | 2.84048630 |
| 8 | MP0004270_analgesia | 2.81533106 |
| 9 | * MP0003634_abnormal_glial_cell | 2.73865221 |
| 10 | MP0004885_abnormal_endolymph | 2.66139636 |
| 11 | MP0001486_abnormal_startle_reflex | 2.53199822 |
| 12 | MP0004742_abnormal_vestibular_system | 2.44467173 |
| 13 | MP0002064_seizures | 2.41088995 |
| 14 | MP0001485_abnormal_pinna_reflex | 2.40213188 |
| 15 | MP0005171_absent_coat_pigmentation | 2.29980240 |
| 16 | MP0003950_abnormal_plasma_membrane | 2.23883663 |
| 17 | MP0003635_abnormal_synaptic_transmissio | 2.21003143 |
| 18 | MP0002272_abnormal_nervous_system | 2.18029728 |
| 19 | MP0003787_abnormal_imprinting | 2.16979871 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.16649805 |
| 21 | MP0003329_amyloid_beta_deposits | 2.14812247 |
| 22 | MP0009745_abnormal_behavioral_response | 2.03397321 |
| 23 | MP0004858_abnormal_nervous_system | 1.99038825 |
| 24 | MP0001529_abnormal_vocalization | 1.95693698 |
| 25 | MP0002735_abnormal_chemical_nociception | 1.93141793 |
| 26 | MP0005623_abnormal_meninges_morphology | 1.86217638 |
| 27 | MP0001905_abnormal_dopamine_level | 1.85270098 |
| 28 | MP0004134_abnormal_chest_morphology | 1.83279380 |
| 29 | MP0010678_abnormal_skin_adnexa | 1.79515408 |
| 30 | * MP0000955_abnormal_spinal_cord | 1.77572189 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.77517867 |
| 32 | MP0002063_abnormal_learning/memory/cond | 1.76085186 |
| 33 | MP0003632_abnormal_nervous_system | 1.74045532 |
| 34 | MP0002653_abnormal_ependyma_morphology | 1.60716287 |
| 35 | MP0005645_abnormal_hypothalamus_physiol | 1.59855176 |
| 36 | MP0003123_paternal_imprinting | 1.59371136 |
| 37 | MP0002572_abnormal_emotion/affect_behav | 1.59331805 |
| 38 | * MP0002882_abnormal_neuron_morphology | 1.59004084 |
| 39 | MP0000383_abnormal_hair_follicle | 1.53279918 |
| 40 | MP0000462_abnormal_digestive_system | 1.52456399 |
| 41 | MP0001501_abnormal_sleep_pattern | 1.47323095 |
| 42 | MP0000467_abnormal_esophagus_morphology | 1.45692327 |
| 43 | MP0001299_abnormal_eye_distance/ | 1.44957716 |
| 44 | MP0009046_muscle_twitch | 1.43672609 |
| 45 | MP0002229_neurodegeneration | 1.42365524 |
| 46 | * MP0002152_abnormal_brain_morphology | 1.41800880 |
| 47 | * MP0004142_abnormal_muscle_tone | 1.40615637 |
| 48 | * MP0002067_abnormal_sensory_capabilities | 1.39998739 |
| 49 | MP0000631_abnormal_neuroendocrine_gland | 1.39717882 |
| 50 | MP0002734_abnormal_mechanical_nocicepti | 1.38551228 |
| 51 | MP0003879_abnormal_hair_cell | 1.37895528 |
| 52 | MP0005409_darkened_coat_color | 1.32995003 |
| 53 | MP0005379_endocrine/exocrine_gland_phen | 1.32469372 |
| 54 | MP0001440_abnormal_grooming_behavior | 1.31050492 |
| 55 | * MP0002066_abnormal_motor_capabilities/c | 1.29274934 |
| 56 | MP0002557_abnormal_social/conspecific_i | 1.28766878 |
| 57 | MP0003937_abnormal_limbs/digits/tail_de | 1.28667056 |
| 58 | MP0000647_abnormal_sebaceous_gland | 1.28527716 |
| 59 | MP0002752_abnormal_somatic_nervous | 1.27935287 |
| 60 | MP0001984_abnormal_olfaction | 1.25740919 |
| 61 | MP0002184_abnormal_innervation | 1.23812376 |
| 62 | MP0002249_abnormal_larynx_morphology | 1.23088809 |
| 63 | MP0002736_abnormal_nociception_after | 1.20686841 |
| 64 | * MP0003861_abnormal_nervous_system | 1.19931148 |
| 65 | MP0003938_abnormal_ear_development | 1.19211450 |
| 66 | MP0001963_abnormal_hearing_physiology | 1.17639224 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 1.16972414 |
| 68 | MP0009250_abnormal_appendicular_skeleto | 1.16640540 |
| 69 | MP0001968_abnormal_touch/_nociception | 1.14242453 |
| 70 | MP0008569_lethality_at_weaning | 1.13669142 |
| 71 | MP0002733_abnormal_thermal_nociception | 1.13618105 |
| 72 | MP0005646_abnormal_pituitary_gland | 1.09925766 |
| 73 | MP0004130_abnormal_muscle_cell | 1.09165261 |
| 74 | MP0000762_abnormal_tongue_morphology | 1.08620915 |
| 75 | MP0003631_nervous_system_phenotype | 1.07769620 |
| 76 | MP0001970_abnormal_pain_threshold | 1.05992667 |
| 77 | MP0005410_abnormal_fertilization | 1.03727232 |
| 78 | MP0003075_altered_response_to | 1.02321555 |
| 79 | MP0001502_abnormal_circadian_rhythm | 1.00463432 |
| 80 | MP0002909_abnormal_adrenal_gland | 0.99456774 |
| 81 | MP0000026_abnormal_inner_ear | 0.99419406 |
| 82 | MP0005195_abnormal_posterior_eye | 0.98305428 |
| 83 | MP0001177_atelectasis | 0.98192409 |
| 84 | MP0005386_behavior/neurological_phenoty | 0.97373685 |
| 85 | MP0004924_abnormal_behavior | 0.97373685 |
| 86 | MP0006276_abnormal_autonomic_nervous | 0.97076619 |
| 87 | MP0000579_abnormal_nail_morphology | 0.90368023 |
| 88 | MP0002233_abnormal_nose_morphology | 0.87494440 |
| 89 | MP0000534_abnormal_ureter_morphology | 0.87363857 |
| 90 | * MP0004811_abnormal_neuron_physiology | 0.85658416 |
| 91 | MP0003633_abnormal_nervous_system | 0.84372707 |
| 92 | MP0006072_abnormal_retinal_apoptosis | 0.83667106 |
| 93 | MP0000639_abnormal_adrenal_gland | 0.82784490 |
| 94 | MP0003755_abnormal_palate_morphology | 0.82696096 |
| 95 | MP0003122_maternal_imprinting | 0.81972166 |
| 96 | MP0001346_abnormal_lacrimal_gland | 0.81842309 |
| 97 | MP0000566_synostosis | 0.80826673 |
| 98 | MP0001340_abnormal_eyelid_morphology | 0.77592306 |
| 99 | MP0000733_abnormal_muscle_development | 0.77433301 |
| 100 | MP0004381_abnormal_hair_follicle | 0.77374445 |
| 101 | MP0001958_emphysema | 0.76844653 |
| 102 | MP0000604_amyloidosis | 0.76597086 |
| 103 | MP0009780_abnormal_chondrocyte_physiolo | 0.76384031 |
| 104 | MP0000747_muscle_weakness | 0.75989584 |
| 105 | * MP0001943_abnormal_respiration | 0.75730782 |
| 106 | MP0003172_abnormal_lysosome_physiology | 0.75672424 |
| 107 | MP0000428_abnormal_craniofacial_morphol | 0.74395951 |
| 108 | MP0002822_catalepsy | 0.74144030 |
| 109 | MP0004043_abnormal_pH_regulation | 0.72491696 |
| 110 | MP0002638_abnormal_pupillary_reflex | 0.72305636 |
| 111 | MP0001986_abnormal_taste_sensitivity | 0.70361507 |
| 112 | MP0002090_abnormal_vision | 0.69576949 |
| 113 | * MP0002069_abnormal_eating/drinking_beha | 0.68217621 |
| 114 | MP0009278_abnormal_bone_marrow | 0.67332428 |
| 115 | MP0001661_extended_life_span | 0.67110586 |
| 116 | MP0005253_abnormal_eye_physiology | 0.66544436 |
| 117 | MP0001293_anophthalmia | 0.66320982 |
| 118 | MP0004145_abnormal_muscle_electrophysio | 0.65738216 |
| 119 | MP0002108_abnormal_muscle_morphology | 0.64870187 |
| 120 | MP0009379_abnormal_foot_pigmentation | 0.64238787 |
| 121 | MP0000537_abnormal_urethra_morphology | 0.64232701 |
| 122 | MP0002163_abnormal_gland_morphology | 0.62971749 |
| 123 | MP0003119_abnormal_digestive_system | 0.54538284 |
| 124 | MP0005535_abnormal_body_temperature | 0.54208603 |
| 125 | MP0001731_abnormal_postnatal_growth | 0.53371939 |
| 126 | MP0005670_abnormal_white_adipose | 0.53113849 |
| 127 | MP0005595_abnormal_vascular_smooth | 0.52535924 |
| 128 | MP0003137_abnormal_impulse_conducting | 0.49417564 |
| 129 | MP0010769_abnormal_survival | 0.48883775 |
| 130 | MP0005394_taste/olfaction_phenotype | 0.48543597 |
| 131 | MP0005499_abnormal_olfactory_system | 0.48543597 |
| 132 | MP0010770_preweaning_lethality | 0.47067407 |
| 133 | MP0002082_postnatal_lethality | 0.47067407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.86543955 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.86543955 |
| 3 | Neurofibrillary tangles (HP:0002185) | 5.05189685 |
| 4 | Abnormality of the corticospinal tract (HP:0002492) | 4.49885343 |
| 5 | Peripheral hypomyelination (HP:0007182) | 4.39824725 |
| 6 | Sensory axonal neuropathy (HP:0003390) | 4.31390260 |
| 7 | Obstructive sleep apnea (HP:0002870) | 4.22029998 |
| 8 | Focal motor seizures (HP:0011153) | 4.06238213 |
| 9 | Diplopia (HP:0000651) | 4.01143664 |
| 10 | Abnormality of binocular vision (HP:0011514) | 4.01143664 |
| 11 | Septo-optic dysplasia (HP:0100842) | 3.90761381 |
| 12 | Cerebral inclusion bodies (HP:0100314) | 3.86625639 |
| 13 | Megalencephaly (HP:0001355) | 3.67583207 |
| 14 | Parakeratosis (HP:0001036) | 3.57983710 |
| 15 | Absent septum pellucidum (HP:0001331) | 3.55276338 |
| 16 | Cerebral hypomyelination (HP:0006808) | 3.41199301 |
| 17 | Spastic gait (HP:0002064) | 3.38832822 |
| 18 | Retinal dysplasia (HP:0007973) | 3.35427374 |
| 19 | Abnormal auditory evoked potentials (HP:0006958) | 3.34282120 |
| 20 | Split foot (HP:0001839) | 3.33977091 |
| 21 | Supranuclear gaze palsy (HP:0000605) | 3.32538441 |
| 22 | Alacrima (HP:0000522) | 3.27585026 |
| 23 | Termporal pattern (HP:0011008) | 3.25266492 |
| 24 | Insidious onset (HP:0003587) | 3.25266492 |
| 25 | Hypoplastic pelvis (HP:0008839) | 3.24788301 |
| 26 | Focal seizures (HP:0007359) | 3.13509245 |
| 27 | Coronal craniosynostosis (HP:0004440) | 3.10181022 |
| 28 | Abnormal eating behavior (HP:0100738) | 3.09381461 |
| 29 | Abnormality of the 4th metacarpal (HP:0010012) | 3.08420056 |
| 30 | Myokymia (HP:0002411) | 3.06238192 |
| 31 | Hemiplegia (HP:0002301) | 3.02522182 |
| 32 | Abnormality of the septum pellucidum (HP:0007375) | 2.95956435 |
| 33 | Abnormality of cochlea (HP:0000375) | 2.93000861 |
| 34 | Relative macrocephaly (HP:0004482) | 2.92157160 |
| 35 | Metabolic alkalosis (HP:0200114) | 2.91894628 |
| 36 | Insomnia (HP:0100785) | 2.90987408 |
| 37 | Premature skin wrinkling (HP:0100678) | 2.85054012 |
| 38 | Intention tremor (HP:0002080) | 2.84967467 |
| 39 | Anteriorly placed anus (HP:0001545) | 2.83547739 |
| 40 | Akinesia (HP:0002304) | 2.82333667 |
| 41 | Epileptic encephalopathy (HP:0200134) | 2.82197012 |
| 42 | Hepatoblastoma (HP:0002884) | 2.79052718 |
| 43 | Oligodactyly (hands) (HP:0001180) | 2.76901351 |
| 44 | Pheochromocytoma (HP:0002666) | 2.76637779 |
| 45 | Onion bulb formation (HP:0003383) | 2.75368093 |
| 46 | Esophageal atresia (HP:0002032) | 2.74665573 |
| 47 | Morphological abnormality of the inner ear (HP:0011390) | 2.74023695 |
| 48 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.66560829 |
| 49 | Dysmetria (HP:0001310) | 2.65548289 |
| 50 | Truncus arteriosus (HP:0001660) | 2.63832731 |
| 51 | Hemiparesis (HP:0001269) | 2.63346052 |
| 52 | Decreased lacrimation (HP:0000633) | 2.61300139 |
| 53 | Humeroradial synostosis (HP:0003041) | 2.61063421 |
| 54 | Synostosis involving the elbow (HP:0003938) | 2.61063421 |
| 55 | Hypokalemic alkalosis (HP:0001949) | 2.60999353 |
| 56 | Congenital malformation of the right heart (HP:0011723) | 2.60972592 |
| 57 | Double outlet right ventricle (HP:0001719) | 2.60972592 |
| 58 | Hyperacusis (HP:0010780) | 2.58968652 |
| 59 | Generalized tonic-clonic seizures (HP:0002069) | 2.58551686 |
| 60 | Overgrowth (HP:0001548) | 2.54082146 |
| 61 | Sleep apnea (HP:0010535) | 2.52958162 |
| 62 | Febrile seizures (HP:0002373) | 2.48408087 |
| 63 | Ankle clonus (HP:0011448) | 2.47628629 |
| 64 | Leukodystrophy (HP:0002415) | 2.41044870 |
| 65 | Elfin facies (HP:0004428) | 2.38981345 |
| 66 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.37622723 |
| 67 | Aplasia of the phalanges of the hand (HP:0009802) | 2.37622723 |
| 68 | Aplasia involving bones of the extremities (HP:0009825) | 2.37622723 |
| 69 | Spastic paraparesis (HP:0002313) | 2.35646279 |
| 70 | Neuroendocrine neoplasm (HP:0100634) | 2.34248213 |
| 71 | Abnormality of glycolysis (HP:0004366) | 2.31695252 |
| 72 | Increased serum pyruvate (HP:0003542) | 2.31695252 |
| 73 | Hyperparathyroidism (HP:0000843) | 2.30708901 |
| 74 | Chin dimple (HP:0010751) | 2.29387685 |
| 75 | Thickened helices (HP:0000391) | 2.27304181 |
| 76 | Fibular hypoplasia (HP:0003038) | 2.24499985 |
| 77 | Germ cell neoplasia (HP:0100728) | 2.24401291 |
| 78 | Lower limb muscle weakness (HP:0007340) | 2.23864129 |
| 79 | Hypoplasia of the iris (HP:0007676) | 2.23863404 |
| 80 | Increased circulating renin level (HP:0000848) | 2.21478115 |
| 81 | Partial agenesis of the corpus callosum (HP:0001338) | 2.19014825 |
| 82 | Truncal ataxia (HP:0002078) | 2.16764987 |
| 83 | Neoplasm of the adrenal cortex (HP:0100641) | 2.15574955 |
| 84 | Overriding aorta (HP:0002623) | 2.14978029 |
| 85 | Scanning speech (HP:0002168) | 2.13216701 |
| 86 | Metaphyseal dysplasia (HP:0100255) | 2.12215579 |
| 87 | Spastic tetraparesis (HP:0001285) | 2.08006552 |
| 88 | Mutism (HP:0002300) | 2.07712243 |
| 89 | Hypoglycemic seizures (HP:0002173) | 2.06792182 |
| 90 | Bowel incontinence (HP:0002607) | 2.06681774 |
| 91 | Optic nerve hypoplasia (HP:0000609) | 2.04084611 |
| 92 | Rib fusion (HP:0000902) | 2.04041510 |
| 93 | CNS hypomyelination (HP:0003429) | 2.03728906 |
| 94 | Slow saccadic eye movements (HP:0000514) | 2.03205689 |
| 95 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.03072801 |
| 96 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.01180734 |
| 97 | Anomalous pulmonary venous return (HP:0010772) | 1.98596072 |
| 98 | Cupped ear (HP:0000378) | 1.97375182 |
| 99 | Synostosis of carpal bones (HP:0005048) | 1.97223235 |
| 100 | Type II lissencephaly (HP:0007260) | 1.96981195 |
| 101 | Abnormal large intestine physiology (HP:0012700) | 1.96674363 |
| 102 | Megalocornea (HP:0000485) | 1.96031537 |
| 103 | Urethral obstruction (HP:0000796) | 1.95273066 |
| 104 | Large earlobe (HP:0009748) | 1.94732236 |
| 105 | Urinary urgency (HP:0000012) | 1.93562764 |
| 106 | Anophthalmia (HP:0000528) | 1.93262167 |
| 107 | Action tremor (HP:0002345) | 1.92522930 |
| 108 | Hypomagnesemia (HP:0002917) | 1.92231354 |
| 109 | Ankyloglossia (HP:0010296) | 1.91882831 |
| 110 | Stereotypic behavior (HP:0000733) | 1.91453055 |
| 111 | Maternal diabetes (HP:0009800) | 1.91054375 |
| 112 | Clumsiness (HP:0002312) | 1.89043408 |
| 113 | Rigidity (HP:0002063) | 1.88592071 |
| 114 | Intellectual disability, moderate (HP:0002342) | 1.87541140 |
| 115 | Anterior segment dysgenesis (HP:0007700) | 1.86483992 |
| 116 | Depression (HP:0000716) | 1.84663511 |
| 117 | Abnormality of the parathyroid morphology (HP:0011766) | 1.84265643 |
| 118 | Partial duplication of thumb phalanx (HP:0009944) | 1.83987449 |
| 119 | Short palpebral fissure (HP:0012745) | 1.82809216 |
| 120 | Laryngomalacia (HP:0001601) | 1.82641177 |
| 121 | Mitral regurgitation (HP:0001653) | 1.81872999 |
| 122 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.81622843 |
| 123 | Hypercalcemia (HP:0003072) | 1.81286585 |
| 124 | Renovascular hypertension (HP:0100817) | 1.80893387 |
| 125 | Obsessive-compulsive behavior (HP:0000722) | 1.80796929 |
| 126 | Hyperaldosteronism (HP:0000859) | 1.78510490 |
| 127 | Absent speech (HP:0001344) | 1.78435141 |
| 128 | Anxiety (HP:0000739) | 1.78127148 |
| 129 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.75758562 |
| 130 | Abnormality of the diencephalon (HP:0010662) | 1.74540944 |
| 131 | Progressive cerebellar ataxia (HP:0002073) | 1.74310961 |
| 132 | Postural instability (HP:0002172) | 1.73477532 |
| 133 | Clonus (HP:0002169) | 1.72306245 |
| 134 | Turricephaly (HP:0000262) | 1.72073248 |
| 135 | Diminished motivation (HP:0000745) | 1.71568446 |
| 136 | Aqueductal stenosis (HP:0002410) | 1.71426610 |
| 137 | Apathy (HP:0000741) | 1.71349721 |
| 138 | Paraparesis (HP:0002385) | 1.70331097 |
| 139 | Torticollis (HP:0000473) | 1.69781545 |
| 140 | Abnormality of the pulmonary veins (HP:0011718) | 1.69679448 |
| 141 | Abnormality of magnesium homeostasis (HP:0004921) | 1.69588976 |
| 142 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.69195646 |
| 143 | Meningocele (HP:0002435) | 1.69006150 |
| 144 | Hypoplasia of the corpus callosum (HP:0002079) | 1.68861086 |
| 145 | Anosmia (HP:0000458) | 1.68764137 |
| 146 | Urinary incontinence (HP:0000020) | 1.68184765 |
| 147 | Missing ribs (HP:0000921) | 1.67616797 |
| 148 | Myelomeningocele (HP:0002475) | 1.66704695 |
| 149 | Epiphyseal dysplasia (HP:0002656) | 1.65897219 |
| 150 | Hammertoe (HP:0001765) | 1.63982856 |
| 151 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.62636694 |
| 152 | Infantile muscular hypotonia (HP:0008947) | 1.62025141 |
| 153 | Pachygyria (HP:0001302) | 1.59507558 |
| 154 | Limb dystonia (HP:0002451) | 1.58335423 |
| 155 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.57930658 |
| 156 | Oligodactyly (HP:0012165) | 1.57866942 |
| 157 | Generalized myoclonic seizures (HP:0002123) | 1.57645497 |
| 158 | Mixed hearing impairment (HP:0000410) | 1.57398281 |
| 159 | Cerebral hemorrhage (HP:0001342) | 1.56795072 |
| 160 | Dysdiadochokinesis (HP:0002075) | 1.56422876 |
| 161 | Atonic seizures (HP:0010819) | 1.56012085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.98045238 |
| 2 | OXSR1 | 3.44354569 |
| 3 | TNIK | 3.13510719 |
| 4 | TYRO3 | 2.84930633 |
| 5 | TNK2 | 2.69795692 |
| 6 | EPHB1 | 2.60675790 |
| 7 | ICK | 2.57629982 |
| 8 | LIMK1 | 2.53281590 |
| 9 | CDK19 | 2.39781543 |
| 10 | PKN1 | 2.33819470 |
| 11 | CASK | 2.25240884 |
| 12 | PRPF4B | 2.17136113 |
| 13 | BCR | 2.01580151 |
| 14 | ERBB4 | 1.94623305 |
| 15 | UHMK1 | 1.94603430 |
| 16 | CSNK1G3 | 1.94036611 |
| 17 | NEK6 | 1.92687491 |
| 18 | PAK6 | 1.91230833 |
| 19 | TESK2 | 1.90932880 |
| 20 | NTRK1 | 1.88969208 |
| 21 | MARK1 | 1.85140728 |
| 22 | FGFR2 | 1.84316232 |
| 23 | MET | 1.83457205 |
| 24 | CSNK1A1L | 1.82743279 |
| 25 | ROCK2 | 1.70225970 |
| 26 | PBK | 1.69013855 |
| 27 | WNK4 | 1.62180942 |
| 28 | CAMKK1 | 1.54603100 |
| 29 | CSNK1G2 | 1.53722754 |
| 30 | MAPKAPK5 | 1.49740717 |
| 31 | FGR | 1.47325471 |
| 32 | NTRK2 | 1.46841963 |
| 33 | CSNK1G1 | 1.44737795 |
| 34 | IRAK2 | 1.43576163 |
| 35 | SGK2 | 1.39006034 |
| 36 | EPHA4 | 1.30991273 |
| 37 | MINK1 | 1.30111563 |
| 38 | PAK3 | 1.25486497 |
| 39 | WNK1 | 1.24264449 |
| 40 | MAP3K9 | 1.23322475 |
| 41 | CDK14 | 1.17190260 |
| 42 | SGK3 | 1.15727744 |
| 43 | STK38L | 1.15714767 |
| 44 | RIPK1 | 1.15502332 |
| 45 | CAMK2B | 1.14688315 |
| 46 | PHKG1 | 1.14085944 |
| 47 | PHKG2 | 1.14085944 |
| 48 | IRAK1 | 1.13440521 |
| 49 | PDGFRB | 1.10412074 |
| 50 | SIK2 | 1.09235585 |
| 51 | PINK1 | 1.09089723 |
| 52 | CDK15 | 1.08247261 |
| 53 | PNCK | 1.07557379 |
| 54 | FES | 1.05523077 |
| 55 | CDK18 | 1.01422774 |
| 56 | CDK11A | 1.01278947 |
| 57 | KSR2 | 0.96741006 |
| 58 | CAMK2D | 0.94395481 |
| 59 | BMX | 0.93774794 |
| 60 | CLK1 | 0.90187624 |
| 61 | MAPK13 | 0.89992224 |
| 62 | CDK5 | 0.88222708 |
| 63 | DYRK2 | 0.87997869 |
| 64 | KSR1 | 0.85648444 |
| 65 | MKNK1 | 0.84685846 |
| 66 | SGK1 | 0.84572231 |
| 67 | PRKCG | 0.84396845 |
| 68 | DAPK2 | 0.82466648 |
| 69 | MUSK | 0.81888364 |
| 70 | PRKD3 | 0.80955801 |
| 71 | DYRK1B | 0.79475013 |
| 72 | CAMK2G | 0.76288298 |
| 73 | SGK223 | 0.73893052 |
| 74 | SGK494 | 0.73893052 |
| 75 | PDGFRA | 0.72241395 |
| 76 | CAMK1 | 0.71031480 |
| 77 | CAMK2A | 0.70827601 |
| 78 | MAPK12 | 0.70259379 |
| 79 | ERBB2 | 0.69778335 |
| 80 | PRKD1 | 0.66871765 |
| 81 | CAMK4 | 0.65904273 |
| 82 | MAP3K13 | 0.60968954 |
| 83 | CAMK1D | 0.60399265 |
| 84 | ROCK1 | 0.59015706 |
| 85 | CSNK1D | 0.58982703 |
| 86 | NTRK3 | 0.58965824 |
| 87 | PRKCZ | 0.58965548 |
| 88 | DYRK1A | 0.58926791 |
| 89 | PRKCH | 0.58509873 |
| 90 | PRKCQ | 0.58064074 |
| 91 | RAF1 | 0.57233144 |
| 92 | FYN | 0.57011072 |
| 93 | LMTK2 | 0.55273283 |
| 94 | ILK | 0.54738919 |
| 95 | TESK1 | 0.53704483 |
| 96 | DMPK | 0.53528022 |
| 97 | MKNK2 | 0.50612978 |
| 98 | STK38 | 0.49118148 |
| 99 | MOS | 0.48246092 |
| 100 | ALK | 0.47771436 |
| 101 | PTK2 | 0.47652206 |
| 102 | PRKCE | 0.45967084 |
| 103 | MAPK15 | 0.45786390 |
| 104 | RET | 0.44789070 |
| 105 | PLK2 | 0.44647045 |
| 106 | DDR2 | 0.43865665 |
| 107 | BRSK1 | 0.43802357 |
| 108 | GSK3A | 0.43511556 |
| 109 | MARK2 | 0.41886482 |
| 110 | CAMKK2 | 0.41162778 |
| 111 | RPS6KA3 | 0.40544569 |
| 112 | STK11 | 0.40067245 |
| 113 | ARAF | 0.38527948 |
| 114 | MAP2K7 | 0.36742642 |
| 115 | PIK3CA | 0.36291667 |
| 116 | MST4 | 0.34386139 |
| 117 | LRRK2 | 0.33437810 |
| 118 | RPS6KB1 | 0.32982928 |
| 119 | MAP3K1 | 0.31881733 |
| 120 | PAK2 | 0.31439316 |
| 121 | MAP2K1 | 0.31294189 |
| 122 | MAP2K4 | 0.31159337 |
| 123 | MAP3K4 | 0.30916706 |
| 124 | INSR | 0.30880742 |
| 125 | CSNK1A1 | 0.30170118 |
| 126 | PRKG1 | 0.29797934 |
| 127 | PAK1 | 0.29582409 |
| 128 | PRKACB | 0.29148154 |
| 129 | SRC | 0.29023836 |
| 130 | CAMK1G | 0.25407821 |
| 131 | PDPK1 | 0.25038283 |
| 132 | MAPK10 | 0.24679697 |
| 133 | CSK | 0.24081601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.71336775 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.14479412 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.40491978 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.37352272 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.22394565 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.03902280 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.52416517 |
| 8 | Axon guidance_Homo sapiens_hsa04360 | 2.44362875 |
| 9 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.22383524 |
| 10 | Insulin secretion_Homo sapiens_hsa04911 | 2.14498305 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.10584778 |
| 12 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.83136114 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.73835859 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.62739075 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.60651026 |
| 16 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.57535968 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.53190652 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.39319571 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.30442351 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.29451960 |
| 21 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.28192856 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28123227 |
| 23 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.27299565 |
| 24 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.26750534 |
| 25 | Endometrial cancer_Homo sapiens_hsa05213 | 1.25976844 |
| 26 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.25860885 |
| 27 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.22548303 |
| 28 | Tight junction_Homo sapiens_hsa04530 | 1.21676537 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.21329920 |
| 30 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.20460341 |
| 31 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.19247830 |
| 32 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.16109053 |
| 33 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.15853633 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.15736085 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.13458162 |
| 36 | Morphine addiction_Homo sapiens_hsa05032 | 1.10888227 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09723159 |
| 38 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.08556952 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08415146 |
| 40 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.05834911 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.04471682 |
| 42 | Circadian entrainment_Homo sapiens_hsa04713 | 1.02660045 |
| 43 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.02264510 |
| 44 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.01146408 |
| 45 | Glioma_Homo sapiens_hsa05214 | 0.98944910 |
| 46 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.95625157 |
| 47 | Nicotine addiction_Homo sapiens_hsa05033 | 0.95616191 |
| 48 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.95496993 |
| 49 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.95419325 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93437151 |
| 51 | Olfactory transduction_Homo sapiens_hsa04740 | 0.93290856 |
| 52 | Cocaine addiction_Homo sapiens_hsa05030 | 0.90661474 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90631254 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.89699875 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89516404 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89472706 |
| 57 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.89444812 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89025452 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88925746 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88662690 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88109605 |
| 62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.87426699 |
| 63 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.86211480 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.85275115 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83557031 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.83330944 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83289770 |
| 68 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.83177633 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.82896813 |
| 70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82530911 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82140348 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.80704827 |
| 73 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.79632308 |
| 74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.78923464 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78371510 |
| 76 | Salivary secretion_Homo sapiens_hsa04970 | 0.78314191 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76102807 |
| 78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.75123189 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74317716 |
| 80 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.74014678 |
| 81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.72477272 |
| 82 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70754722 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70576625 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.67514901 |
| 85 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.67457972 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67300400 |
| 87 | Melanogenesis_Homo sapiens_hsa04916 | 0.66156440 |
| 88 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.63640863 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63624944 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61511086 |
| 91 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61485660 |
| 92 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.61252724 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59945848 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59613688 |
| 95 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58176516 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57460131 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55190286 |
| 98 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.54962072 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53021568 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52034385 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.51493682 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51316269 |
| 103 | Long-term potentiation_Homo sapiens_hsa04720 | 0.51152391 |
| 104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50434725 |
| 105 | Alcoholism_Homo sapiens_hsa05034 | 0.50422153 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49858719 |
| 107 | Protein export_Homo sapiens_hsa03060 | 0.48092016 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47476296 |
| 109 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47405774 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47393818 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46960851 |
| 112 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46935463 |
| 113 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46410994 |
| 114 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46011427 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45843554 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45539047 |
| 117 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45024446 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.43083247 |
| 119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42856191 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.42618502 |
| 121 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41880725 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40873607 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40424592 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40387580 |
| 125 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.40051138 |
| 126 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.39875489 |
| 127 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.39299020 |
| 128 | Melanoma_Homo sapiens_hsa05218 | 0.39222899 |
| 129 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38976010 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36641042 |
| 131 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35318496 |
| 132 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.34921274 |

